Anti-Fibrosis Effect of Scutellarin via Inhibition of Endothelial–Mesenchymal Transition on Isoprenaline-Induced Myocardial Fibrosis in Rats
Open Access
- 29 September 2014
- Vol. 19 (10) , 15611-15623
Abstract
Scutellarin (SCU) is the major active component of breviscapine and has been reported to be capable of decreasing myocardial fibrosis. The aim of the present study is to investigate whether SCU treatment attenuates isoprenaline-induced myocardial fibrosis and the mechanisms of its action. Rats were injected subcutaneously with isoprenaline (Iso) to induce myocardial fibrosis and rats in the SCU treatment groups were intraperitoneally infused with SCU (10 mg·kg−1·d−1 or 20 mg·kg−1·d−1, for 14 days). Post-treatment, cardiac functional measurements and the left and right ventricular weight indices (LVWI and RVWI, respectively) were analysed. Pathological alteration, expression of type I and III collagen, Von Willebrand factor, α-smooth muscle actin, cluster of differentiation-31 (CD31), and the Notch signalling proteins (Notch1, Jagged1 and Hes1) were examined. The administration of SCU resulted in a significant improvement in cardiac function and decrease in the cardiac weight indices; reduced fibrous tissue proliferation; reduced levels of type I and III collagen; increased microvascular density; and decreased expression of α-smooth muscle actin and increased expression of CD31, Notch1, Jagged1 and Hes1 in isoprenaline-induced myocardial fibrosis in rats. Our results suggest that SCU prevents isoprenaline-induced myocardial fibrosis via inhibition of cardiac endothelial-mesenchymal transition potentially, which may be associated with the Notch pathway.Keywords
Funding Information
- Zhejiang Provincial Natural Science Foundation of China (LY12H02004)
- Foundation for the Program of Science and Technology Department of Zhejiang Province of China (2014C33166)
- Foundation for the program of provincial health department of zhejiang province of China (2014KYA136)
This publication has 18 references indexed in Scilit:
- Relaxin Prevents Cardiac Fibroblast-Myofibroblast Transition via Notch-1-Mediated Inhibition of TGF-β/Smad3 SignalingPLOS ONE, 2013
- Role of Endothelial-Mesenchymal Transition (EndoMT) in the Pathogenesis of Fibrotic DisordersThe American Journal of Pathology, 2011
- Scutellarin alleviates interstitial fibrosis and cardiac dysfunction of infarct rats by inhibiting TGFβ1 expression and activation of p38‐MAPK and ERK1/2British Journal of Pharmacology, 2010
- TGF-β-induced epithelial to mesenchymal transitionCell Research, 2009
- The promoting angiogenesis and anti-inflammation effect of scutellarin on polyglycolic acid scaffold of balb/c mice modelJournal of Asian Natural Products Research, 2008
- Transforming Growth Factor β–Induced Endothelial-to-Mesenchymal Transition: A Switch to Cardiac Fibrosis?Trends in Cardiovascular Medicine, 2008
- Scutellarin‐induced endothelium‐independent relaxation in rat aortaPhytotherapy Research, 2008
- TGF-β-induced EMT: mechanisms and implications for fibrotic lung diseaseAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2007
- Protective Effects of Scutellarin and Breviscapine on Brain and Heart Ischemia in RatsJournal of Cardiovascular Pharmacology, 2007
- Studies on isoproterenol-induced cardiomegaly in ratsAmerican Heart Journal, 1969